Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02704481 · ClinicalTrials.gov registry record · Phase 4
Non-surgical Alternatives to Treatment of Failed Medical Abortion
A Phase 4 study, sponsored by Gynuity Health Projects.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02704481: Clinical Trial Phase 4 study, sponsored by Gynuity Health Projects.
NCT02704481 is a Phase 4 study that was terminated before completion, run by Gynuity Health Projects. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02704481, a Phase 4 study, was terminated before completion, sponsored by Gynuity Health Projects.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.
Interventions
- DRUG Mifepristone
- DRUG Misoprostol
- DRUG Placebo mifepristone
- DRUG Placebo misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2019-01-16 |
| Phase | Phase 4 |
Why NCT02704481 stopped before completion
NCT02704481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Mifepristone is the first listed.
NCT02704481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02704481 about?
NCT02704481 is a clinical study titled "Non-surgical Alternatives to Treatment of Failed Medical Abortion". The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.
What is the current status of trial NCT02704481?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2016-06-01. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT02704481?
The interventions under investigation include: Mifepristone (DRUG), Misoprostol (DRUG), Placebo mifepristone (DRUG), Placebo misoprostol (DRUG).
Who is sponsoring clinical trial NCT02704481?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02704481's enrollment target sits among peer trials
16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI